All News

    FDA Approves Orserdu for Some Patients with Metastatic Breast Cancer

    January 27th 2023

    The Food and Drug Administration approved Orserdu for patients with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.

    FDA Approves Jaypirca for Relapsed/Refractory Mantle Cell Lymphoma

    January 27th 2023

    The Food and Drug Administration approved Jaypirca for patients with relapsed/refractory mantle cell lymphoma who have been previously treated with multiple lines of therapy.

    The Day I Realized My Oncologist Was a Real Person

    January 27th 2023

    I always viewed my doctors as being unapproachable on a personal level. I thought they were there to examine and diagnose me, imparting wisdom I could never hope to attain, but one day I realized I was very wrong.

    Michael Bublé Discusses His Son’s Cancer, TikTok Star Dies of CRC and More

    January 27th 2023

    From Michael Bublé opening up about his son’s cancer diagnosis to the death of “Enkyboys” social media star, here’s what’s happening in the oncology space this week.

    Trial to Investigate Novel Drug in KRAS-Mutant Lung Cancer

    January 27th 2023

    VIC-1911 will be studied alone or with Lumakras in patients with KRAS G12C-mutant non-small cell lung cancer.

    FDA Approves Post-Surgical Keytruda for Lung Cancer Subset

    January 26th 2023

    The Food and Drug Administration approved Keytruda, an immunotherapy agent, for patients with stage 1B, 2 or 3A non-small cell lung cancer.

    Iadademstat-Placebo Combo to Be Studied in Neuroendocrine Cancers

    January 26th 2023

    Researchers just launched a phase 2 trial evaluating iadademstat plus paclitaxel in patients with relapsed/refractory neuroendocrine cancer, including those with small cell lung cancer.

    Acknowledging Cancer-Related Cognitive Impairment May Be Best Treatment for Breast Cancer Survivors Versus Physical, Mindfulness Exercises

    January 26th 2023

    When comparing mindfulness activities with physical exercise and no exercise to treat cancer-related cognitive impairment, breast cancer survivors showed similar outcomes across the board, leading researchers to suggest acknowledging the side effect may help patients cope.

    'Cancer Ghosting' Is an Unfortunate Reality

    January 26th 2023

    Losing my breasts was hard, but losing one of my best friends was even harder, and something I’ve had to come to terms with.

    Single-Arm Versus Randomized Trials for FDA Approvals of Cancer Drugs

    January 26th 2023

    An expert from the FDA explained the benefits and limitations of these two clinical trial formats and how the cancer field can learn from both.

    Is There a Scale for Cancer Survivorship?

    January 26th 2023

    My cancer was caught early, and I never had to have chemotherapy — leading me experience survivor’s guilt and ask, “can I even call myself a survivor?”

    Phase 3 Trial in Prostate Cancer Subset Discontinued Due to Lack of Survival Benefit

    January 26th 2023

    A data monitoring committee recommended to stop the phase 3 trial in metastatic hormone-sensitive prostate cancer due to a lack of progression-free survival and overall survival with combination therapy.

    Low-Dose Immunotherapy Boosts Survival in Head and Neck Cancer

    January 25th 2023

    Opdivo — even when given in a low dose — was shown to improve outcomes in patients with advanced head and neck squamous cell carcinoma, highlighting a new option for patients who cannot receive the full dose.

    Researchers Are ‘Building Up the Wall of Evidence’ to Support Cancer Vaccines in the Future

    January 25th 2023

    As more news is released about studies assessing cancer vaccines, one expert explains what this may mean for patients in the future.

    Finding Our Purpose After Cancer

    January 25th 2023

    Here are four ways I found purpose in my life after being diagnosed with cancer.

    Cancer Is Like a Race, and I’m Determined to Win

    January 25th 2023

    Cancer — and its treatments — can feel like a grueling race, but I’m using frequent follow-ups and an excellent care team to stay ahead of the game.

    Adding Avastin to Lonsurf Improved Outcomes in Pretreated Colorectal Cancer

    January 25th 2023

    Patients with pretreated metastatic colorectal cancer had better outcomes when Avastin was added to their Lonsurf treatment in the third line setting.

    SBRT Reduces Side Effects, Treatment Visits in Pancreatic Cancer

    January 24th 2023

    Patients with pancreatic cancer who underwent stereotactic body radiation tended to have fewer side effects and treatment sessions compared to those who had intensity-modulated radiation therapy.

    Seeking Support Helps 'Normalize the Ambivalence' Felt With Body Image, Self Perception During Cancer

    January 24th 2023

    Although patients with cancer may feel both grateful and grief towards their bodies, one expert emphasizes how important seeking support from a professional can be throughout this process.

    A Small, Inspiring Bushy-Tailed Visitor as a Distraction From Cancer

    January 24th 2023

    When my wife was going through cancer treatments, she sometimes would color my artwork as a distraction. Here’s an activity I made for other survivors, now that it’s the year of the rabbit.

    Tukysa-Herceptin Approval for Colorectal Cancer Is an ‘Important Breakthrough’ for Chemo-Resistant Disease

    January 24th 2023

    The FDA recently approved a combination treatment for patients with previously treated metastatic colorectal cancer with HER2-positive disease determined by biomarker testing.

    Novel Drug to Be Tested in Rare Form of Eye Cancer

    January 24th 2023

    A phase 2 study will investigate the efficacy of darovasertib for patients with uveal melanoma and whether the drug can potentially result in lower radiation doses or fewer eye removal surgeries.

    Better Quality of Life Reported with Minimally Invasive Esophageal Cancer Treatment

    January 23rd 2023

    Patients who underwent minimally invasive treatment tended to have better quality-of-life outcomes than those who had a full esophagus removal, though there were risk factors for long-term outcomes that should be considered.

    Wondering ‘Why Me’ After a Cancer Diagnosis

    January 23rd 2023

    I exercised and ate healthy, yet still received a cancer diagnosis, leaving me wondering, “why me?”

    She With Lynch Syndrome

    January 23rd 2023

    I recently met another woman with Lynch syndrome, the same hereditary cancer syndrome that I have, and it made me reflect on the steps I was taking to maintain my health.

    How Cancer Affects Survivors’ Relationship With Their Hair

    January 23rd 2023

    We surveyed the CURE® audience about how cancer impacted their relationship with their hair. Here’s what they had to say.

    Lenvima May Prolong Survival in Advanced Liver Cancer That Progressed on Immunotherapy

    January 23rd 2023

    Patients with advanced HCC who progressed after treatment with immunotherapy may have a survival benefit when treated with second-line Lenvima.

    Quitting Smoking and Drinking May Decrease Depression Risk After Gastric Cancer Surgery

    January 22nd 2023

    Patients with gastric cancer who quit smoking and/or drinking after undergoing a gastrectomy tended to have a decreased risk of depression, research showed.

    Novel Drug-Chemo Combo May Offer ‘New Standard of Care’ for Certain GI Cancers

    January 21st 2023

    Zolbetuximab plus mFOLFOX6 lengthened the time to progression for patients with CLDN18.2-positive, HER2-negative locally advanced unresectable or metastatic gastric/gastroesophageal junction (GEJ) adenocarcinoma.

    First Patient with Colorectal Cancer Received Nanrilkefusp Alfa in Phase 2 Trial

    January 21st 2023

    The multicenter study is evaluating the safety and efficacy of nanrilkefusp alfa combined with Erbitux.

    NEXT PAGE
    PREVIOUS PAGE